| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |